Literature DB >> 23125402

Association of risk factors with acute myocardial infarction in Middle Eastern countries: the INTERHEART Middle East study.

Abdurrazzak A Gehani1, Ali T Al-Hinai, Mohammad Zubaid, Wael Almahmeed, M R Mohammad Hasani, Afzal Hussein Yusufali, Mohammed Osman Hassan, Basil S Lewis, Shofiqul Islam, Sumathy Rangarajan, Salim Yusuf.   

Abstract

BACKGROUND AND OBJECTIVES: Mortality from cardiovascular disease in the Middle East (ME) is projected to increase substantially by 2020. There are no large studies on the impact of risk factors for acute myocardial infarction (AMI) in the region. This is a report on the association of nine risk factors with AMI in the ME. METHODS AND
RESULTS: As part of the INTERHEART (IH) study, we enrolled 1364 cases of first AMI and 1525 matching controls from eight ME countries. The age at first AMI was 51.2 ± 10.3 years, which is the youngest, and with the largest proportion of patients <40 years in the entire IH population. The overall population attributable risk (PAR) of the nine risk factors to AMI was higher in the ME (97.5%) than worldwide (90.4%). Elevated apolipoprotein (Apo)B/ApoA1 had the strongest association with AMI, with odds ratio (OR) of 3.43 and PAR of 57.1%, followed by smoking (OR 3.63 and PAR 45.6%). ApoB/ApoA1 had greater association than the conventional low-density lipoprotein (LDL)/high-density lipoprotein (HDL) cholesterol ratio. Both diabetes (OR 3.42, PAR 16.4%) and hypertension (OR 1.89, PAR 10.7%) had greater association with AMI in women than men. Abdominal obesity (OR 2.12, PAR 26.1%) and depression (OR 1.97, PAR 45.3%), but not conventional BMI, were significantly associated with AMI (p < 0.0001).
CONCLUSION: This is the largest prospective population study of risk factors associated with AMI in the ME. AMI occurs at younger age in the ME than all other regions. The PAR for the nine risk factors was higher in the ME (97.5%) than the rest of the world. These findings should guide serious prevention strategies.

Entities:  

Keywords:  Cardiovascular disease; Middle East; epidemiology; lipoproteins; myocardial infarction; obesity; risk factors

Mesh:

Year:  2012        PMID: 23125402     DOI: 10.1177/2047487312465525

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  39 in total

1.  Dyslipidemia in the Arabian Gulf and its Impact on Cardiovascular Risk Outcome.

Authors:  Khalid Al-Rasadi; Hilal Al-Sabti
Journal:  Oman Med J       Date:  2015-11

Review 2.  Premature Myocardial Infarction in the Middle East and North Africa: Rationale for the Gulf PREVENT Study.

Authors:  Sagar B Dugani; Waheed Murad; Karisamae Damilig; Jean Atos; Eshraga Mohamed; Edward Callachan; Zareen Farukhi; Arshia Shaikh; Abubaker Elfatih; Salwa Yusef; Yousif M Hydoub; M Vinayaga Moorthy; Bassem Mora; Ahlam Alawadhi; Robin Issac; Abdulkarim Saleh; Arif Al-Mulla; Samia Mora; Alawi A Alsheikh-Ali
Journal:  Angiology       Date:  2019-05-26       Impact factor: 3.619

3.  Subclinical atherosclerosis detected by coronary computed tomographic angiography in Qatar: a comparison between Qataris and south Asian migrants.

Authors:  Joshua Schulman-Marcus; Ran Heo; Heidi Gransar; Jassim Al Suwaidi; Maryam Alkuwari; Kimberly Elmore; Mille J Gomez; Amin Jayyousi; Mahmoud Zirie; James K Min; Jessica M Peña
Journal:  Int J Cardiovasc Imaging       Date:  2017-01-27       Impact factor: 2.357

Review 4.  Depression in Cardiovascular Patients in Middle Eastern Populations: A Literature Review.

Authors:  Tam Truong Donnelly; Jassim Mohd Al Suwaidi; Awad Al-Qahtani; Nidal Asaad; Najlaa Abdul Qader; Rajvir Singh; Tak Shing Fung; Irem Mueed; Shima Sharara; Noha El Banna; Sarah Omar
Journal:  J Immigr Minor Health       Date:  2015-08

Review 5.  Coronary Heart Disease in the Middle East and North Africa: Current Status and Future Goals.

Authors:  Mahmoud I Traina; Wael Almahmeed; Ahmad Edris; E Murat Tuzcu
Journal:  Curr Atheroscler Rep       Date:  2017-05       Impact factor: 5.113

Review 6.  Global epidemiology of dyslipidaemias.

Authors:  Angela Pirillo; Manuela Casula; Elena Olmastroni; Giuseppe D Norata; Alberico L Catapano
Journal:  Nat Rev Cardiol       Date:  2021-04-08       Impact factor: 32.419

7.  Mortality Trends in Patients Hospitalized with the Initial Acute Myocardial Infarction in a Middle Eastern Country over 20 Years.

Authors:  Emad Ahmed; Jassim Al Suwaidi; Ayman El-Menyar; Hajar A H AlBinali; Rajvir Singh; A A Gehani
Journal:  Cardiol Res Pract       Date:  2014-04-28       Impact factor: 1.866

8.  Short- and long-term outcomes in Middle Eastern diabetic patients after percutaneous coronary intervention: results from The First Jordanian PCI Registry (JoPCR1).

Authors:  Ayman J Hammoudeh; Ramzi Tabbalat; Imad A Alhaddad; Yousef Khader; Mohamad Jarrah; Mahmoud Izraiq; Eyas Al-Mousa
Journal:  Diabetol Int       Date:  2016-05-03

9.  Sex Differences in Stroke Incidence, Prevalence, Mortality and Disability-Adjusted Life Years: Results from the Global Burden of Disease Study 2013.

Authors:  Suzanne Barker-Collo; Derrick A Bennett; Rita V Krishnamurthi; Priya Parmar; Valery L Feigin; Mohsen Naghavi; Mohammed H Forouzanfar; Catherine O Johnson; Grant Nguyen; George A Mensah; Theo Vos; Christopher J L Murray; Gregory A Roth
Journal:  Neuroepidemiology       Date:  2015-10-28       Impact factor: 3.282

10.  Cardiovascular risk factor burden in Africa and the Middle East: the Africa Middle East Cardiovascular Epidemiological (ACE) study.

Authors:  Alawi A Alsheikh-Ali; Mohamed I Omar; Frederick J Raal; Wafa Rashed; Omar Hamoui; Abdoul Kane; Mohamed Alami; Paula Abreu; Walid M Mashhoud
Journal:  PLoS One       Date:  2014-08-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.